Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
NCT03400501
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
Insulin Degludec
DRUG:
Insulin Glargine
Sponsor
Yale University